Ohana Biosciences Announces Appointment of David Sable, MD, to Board of Directors
CAMBRIDGE, Mass .-- (COMMERCIAL THREAD) - Ohana Biosciences, a clinical-stage biotechnology company pioneering reproductive health through the industry's first semen biology platform, today announced the appointment of David Sable, MD, to…